CBRE Group, Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

CBRE Group Inc (CBRE) Stock Up 4.7% and Still Undervalued -- GF Score: 95/100 - GuruFocus

AI-generated analysis

📈 CBRE shares rose 4.7% to close at $148.74, trading 7.0% below its GF Value™ estimate of $159.90.

📊 The company achieved a high GF Score™ of 95/100, reflecting exceptional performance in growth and valuation categories.

⚠️ Insider activity shows $2.7M in stock sales over the past year with no corresponding purchasing activity.

📉 CBRE's current P/E ratio of 34.1x is 11% above its five-year historical median of 30.7x.

💰 The forward P/E ratio of 16.3x suggests a more favorable outlook for future earnings potential.

🏦 Financial strength metrics received a lower rating of 6/10 compared to perfect scores in growth and valuation.

👥 Guru ownership is divided, with an equal split of investors adding to or trimming their stakes in recent quarters.

Bullish Signals
  • CBRE shares are trading 7.0% below its GF Value™ estimate of $159.90, suggesting the stock is undervalued relative to intrinsic value calculations.
  • The company achieved a perfect score of 10/10 in growth and valuation metrics within its comprehensive GF Score™ assessment.
  • A forward P/E ratio of 16.3x indicates favorable future earnings potential compared to the current trailing twelve-month P/E of 34.1x.
Risk Factors
  • Insider selling activity totaled $2.7M over the past year with no buying activity, which may signal a lack of confidence in the short-term outlook.
  • The company's financial strength score is only 6/10, indicating potential vulnerabilities despite strong performance in other areas like growth and profitability.
Full Analysis
CBRE Group Inc (CBRE) shares rose 4.7% on September 03, 2026, closing at $148.74. The stock is currently trading approximately 7.0% below its GuruFocus GF Value™ estimate of $159.90, which the platform interprets as a potential undervaluation offering a margin of safety for investors. The company's financial health is assessed via a comprehensive GF Score™ of 95/100, driven by perfect scores in growth and valuation metrics alongside strong profitability. However, the analysis highlights a financial strength score of only 6/10, suggesting specific vulnerabilities that warrant monitoring despite the overall robust operational performance indicated by the high aggregate score. Valuation metrics show CBRE trading at a trailing twelve-month P/E ratio of 34.1x, which is 11% above its five-year median of 30.7x, indicating a higher current valuation relative to history. Conversely, the forward P/E stands at 16.3x, suggesting more favorable future earnings potential that aligns with the undervalued verdict based on intrinsic value estimates.